Advertisement

Transfusion/Therapie mit Blutkomponenten

  • A. Lorentz

Zusammenfassung

Die Transfusion von Blut oder von Blutkomponenten dient der Behebung eines Defizits. Ein therapiebedürftiges Defizit besteht in den allermeisten Fällen nicht für alle Fraktionen des Blutes, deshalb stellt eine Therapie mit Blutkomponenten sowohl aus medizinischen wie auch aus ökonomischen Gründen den rationalen Weg der Transfusionstherapie dar.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aster RH, Handl JB (1961) Platelet sequestration in man. I. Methods. J Clin Invest 13:843Google Scholar
  2. Bahn SL, Mursh PJ (1980) The effect of cold on hemostasis. Oral Surg 49:294PubMedCrossRefGoogle Scholar
  3. Bergmann H (1976) Risiken der Infusions- und Transfusionstherapie. Anästhesiol Inform 17:440Google Scholar
  4. Beutler F (1977) International forum: What is the clinical importance of alterations of the hemoglobin oxygen affinity in preserved blood especially as produced by variations of red cell 2,3 DPG content? Vox Sang 4:1Google Scholar
  5. Brand A, Leeuwen A van, Eernisse JG et al. (1978) Platelet transfusion therapy. Optimal donor selection with a combination of lymphotoxicity and platelet fluorescence tests. Blood 51:781PubMedGoogle Scholar
  6. Brettler DB (1985) Granulocytopenia. In: Rippe JM, Irwin RS, Alpert JS, Dalen JE, Intensive care medicine. Little, Brown, BostonGoogle Scholar
  7. Brzica SM (1978) Common transfusion problems. In: Brzica SM (ed) Blood transfusion dilemas. American Association of Blood Banks, Washington DC, pp 1–9Google Scholar
  8. Collins JA (1978) Massive transfusion: What is current and important? In: Nusbacher J (ed) Massive transfusion. (Symposium of the Am. Assoc. Blood Banks, Washington/DC)Google Scholar
  9. Collins JA, Högman CF, Lundsgaard-Hansen P, Snyder E, Swank RL, Wenz B (1986) When is microfiltration of whole blood and red cell concentrates essential? When is it superfluous? International Forum. Vox Sang 45:217Google Scholar
  10. Denlinger JK, Narhwold ML, Gibbs PS (1976) Hypocalcaemia during rapid blood transfusion in anaesthesized man. Br J Anaesth 48:995PubMedCrossRefGoogle Scholar
  11. Frey-Wettstein M, Barandun S, Blicher U, Bütler R, Metaxas M (1986) Die Biuttransfusion. Ein Vademecum. Karger, BaselGoogle Scholar
  12. Goldfinger D (1977) Acute hemolytic transfusion reactions – a fresh look at pathogenesis and considerations regarding therapy. Transfusion 17:85PubMedCrossRefGoogle Scholar
  13. Hadstrand U, Högman CF, Zaren B, Lundkvist R (1987) Postoperative complications following blood replacement with and wihtout plasma in elective surgery. Acta Chir Scand 153:501Google Scholar
  14. Högman CF, Åkerblom O, Hedlund K, Rosen I, Wiklund I (1983) Red cell survival in SAGM medium. Further experience of in vivo survival of red cells, clinical usefulness and plasma saving effects. Vox Sang 45:217PubMedCrossRefGoogle Scholar
  15. Högman CF, Bagge L, Thoren L (1987) The use of blood components in surgical transfusion therapy. World J Surg 11:2PubMedCrossRefGoogle Scholar
  16. Howland WS (1978) Calcium, potassium and pH changes during massive transfusion. In: Nusbacher J (ed) Massive transfusion. (Symposium of the Am. Assoc. Blood Banks, Washington DC)Google Scholar
  17. Kark JA (1982) Malaria transmitted by blood transfusion. In: Tabor E (ed) Infectious complications of blood transfusion. Academic Press, New York London, pp 92–126Google Scholar
  18. Klose R (1984) Problematik der akuten Blutung in der Anaesthesie. In: Gerinnungsprobleme in der Intensivmedizin. Gerinnungssymposium der Behringwerke anläßlich des Zentraleuropäischen Anaesthesiekongresses 13.–17.9. 1983. Behring, Marburg.Google Scholar
  19. Lundsgaard-Hansen P (1980) Component therapy of surgical hemorrhage. Bibl Haematol 46:147PubMedGoogle Scholar
  20. Lundsgaard-Hansen P, Tschirren B (1980) Verwendung von Plasmaersatzmitteln und Albumin im Rahmen der Komponententherapie. In: Ahnefeld FW, Bergmann H, Burri C (Hrsg) Klinische Anästhesiologie und Intensivtherapie, Bd 21. Springer, Berlin Heidelberg New York S.210ffGoogle Scholar
  21. Marshall BE, Wurzel HA, Ellison N, Neufeld GR, Somar LR (1975) Microaggregate formation in stored blood. III. Comparison of Bentley, Fenwal, Pall and Swank micropore filtration. Circ Shock 2:249Google Scholar
  22. Miller RD (1973) Complications of massive blood transfusion. Anaesthesiology 39:82CrossRefGoogle Scholar
  23. Mollison PL, Engelfriet CP, Contreras M (1987) Blood transfusion in clinical medicine. Blackwell, OxfordGoogle Scholar
  24. Müller-Eberhard HJ (1975) The complement system. In: Putman FW (ed) The plasma proteins. Vol 1. Academic Press, New York p 393Google Scholar
  25. Ostendorf P, Jaschonek K (1982) Hämotherapie plasmatischer Gerinnungsstörungen. In: Schneider W, Schorer R (Hrsg) Klinische Transfusionsmedizin. edition medizin, WeinheimGoogle Scholar
  26. Prins HK, de Bruyn JCGH, Henrichs HPJ, Loos JA (1980) Prevention of microaggregate formation by removal of “buffycoats”. Vox Sang 39:48Google Scholar
  27. Schiffer CA (1980) Clinical importance of antiplatelet antibody testing for the blood bank. In: Bell CA (ed) A seminar on antigens on blood cells and body fluids. American Association of Blood Banks, Washington DC, pp 189–208Google Scholar
  28. Schiffer CA (1984) Transfusion therapy in the critical care setting. In: Shoemaker WC, Thompson WL, Holbrock PR (eds) Textbook of critical care. Saunders, PhiladelphiaGoogle Scholar
  29. Schneider W (1971) Zur Frage der Haufigkeit von Transfusionsreaktionen durch regulare und irreguläre Antikörper. In: Matthes M, Kleine N, Holländer LP (Hrsg) Ergebnisse der Bluttransfusionsforschung. Karger, Basel, S 162–165Google Scholar
  30. Schott U, Sjøstrand U, Thoren T, Berseus O (1985) Three precent dextran 60 as a plasma substitute in blood component therapy. Acta Anesthesiol Scand 29:767CrossRefGoogle Scholar
  31. Schricker KT (1988) Der Transfusionszwischenfall. Anaesth Intensivmed 29:37Google Scholar
  32. Sheldon GF (1977) International forum: What is the clinical importance of alterations of the hemoglobin oxygen affinity in preserved blood especially as produced by variations of red cell 2,3 DPG content? Vox Sang 4:1Google Scholar
  33. Simpson MB (1978) Platelet function and transfusion in the surgical patient. In: Schiffer CH (ed) Platelet physiology and transfusion. American Association of Blood Banks, Washington DC, pp 51–67Google Scholar
  34. Slichter SJ, Harker LA (1976) Preparation and storage of platelet concentrates. Br J Haematol 34:395PubMedCrossRefGoogle Scholar
  35. Spielman W, Seidl S (1980) Einführung in die Immunhamatologie und Transfusionskunde. Verlag Chemie, WeinheimGoogle Scholar
  36. Spilker D, Kilian J (1987) Der hämorrhagisch-traumatische Schock. In: Kilian J, Messmer K, Ahnefeld FW (Hrsg) Schock. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  37. Stephen CR, Martin RC, Bourgeois-Gavardin M (1955) Antihistaminic drugs in treatment of nonhemolytic transfusion reactions. JAMA 158:525Google Scholar
  38. Sugg U (1986) Zum Problem der posttransfusionellen Hepatitis. Beitr Infusionsther Klin Ernähr 15:30Google Scholar
  39. Sugg U (1987) Die Risiken der Transfusion von Blut und Blutderivaten. Anästhesiol Intensivmed 28:343Google Scholar
  40. Swank RL (1961) Alteration of blood on storage: measurement of adhesiveness of aging platelets and leukocytes and their removal by filtration. N Engl J Med 265:728PubMedCrossRefGoogle Scholar
  41. Tabor E (1982) Transfusion transmitted infections. In: Tabor E (ed) Infectious complications of blood transfusion. Academic Press, New York London, pp 87–92Google Scholar
  42. Thomas BA, Hessel LA, Harker MP, Sands MP, Dillard D H (1981) Platelet function during and after deep surface hyothermia. J Surg Res 31:314PubMedCrossRefGoogle Scholar
  43. Vyas GN, Holmdahl L, Perkins HA, Fudenberg HH (1969) Serological specifity of human antiIgA and its significance in blood transfusion. Blood 34:573PubMedGoogle Scholar
  44. Zimmerman TS, Muller-Eberhard HJ (1971) Blood coagulation initiation by a complement mediated pathway. J Exp Med 134:1601PubMedCrossRefGoogle Scholar
  45. Zistl F (1988) Notfalltransfusion. Anästh Intensivrned 29:21Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • A. Lorentz

There are no affiliations available

Personalised recommendations